|
BIMI International Medical, Inc. (BIMI) DCF -Bewertung
CN | Healthcare | Medical - Pharmaceuticals | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
BIMI International Medical, Inc. (BIMI) Bundle
Gewinnen Sie einen Einblick in Ihre Bewertungsanalyse von BIMI International Medical, Inc. (BIMI) unter Verwendung unseres modernsten DCF-Taschenrechners! Diese Excel -Vorlage wird mit realen BIMI -Daten vorinstalliert, sodass Sie Prognosen und Annahmen für eine genaue Berechnung des intrinsischen Wertes von BIMI anpassen können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2018 |
AY2 2019 |
AY3 2020 |
AY4 2021 |
AY5 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.5 | .2 | 12.8 | 27.1 | 11.8 | 13.2 | 14.7 | 16.4 | 18.3 | 20.4 |
| Revenue Growth, % | 0 | -97.59 | 8030.82 | 110.82 | -56.31 | 11.53 | 11.53 | 11.53 | 11.53 | 11.53 |
| EBITDA | -15.5 | -1.7 | -3.2 | -32.0 | -18.0 | -11.2 | -12.5 | -13.9 | -15.6 | -17.3 |
| EBITDA, % | -237.6 | -1084.38 | -25 | -118.08 | -151.88 | -85 | -85 | -85 | -85 | -85 |
| Depreciation | 1.0 | .3 | .1 | .2 | .2 | 3.1 | 3.5 | 3.9 | 4.4 | 4.9 |
| Depreciation, % | 15.88 | 165.84 | 0.43629 | 0.90147 | 1.89 | 23.82 | 23.82 | 23.82 | 23.82 | 23.82 |
| EBIT | -16.6 | -2.0 | -3.3 | -32.2 | -18.2 | -11.2 | -12.5 | -14.0 | -15.6 | -17.4 |
| EBIT, % | -253.48 | -1250.21 | -25.43 | -118.98 | -153.77 | -85.09 | -85.09 | -85.09 | -85.09 | -85.09 |
| Total Cash | .0 | .0 | .1 | 4.8 | 2.3 | 1.6 | 1.8 | 2.0 | 2.3 | 2.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.3 | .0 | 8.3 | 6.3 | 4.2 | 4.0 | 4.4 | 4.9 | 5.5 | 6.1 |
| Account Receivables, % | 20.49 | 6.39 | 64.92 | 23.43 | 35.29 | 30.11 | 30.11 | 30.11 | 30.11 | 30.11 |
| Inventories | .9 | .7 | .7 | 2.6 | 7.7 | 5.1 | 5.7 | 6.4 | 7.1 | 7.9 |
| Inventories, % | 14.34 | 447.86 | 5.72 | 9.75 | 64.7 | 38.9 | 38.9 | 38.9 | 38.9 | 38.9 |
| Accounts Payable | .0 | .0 | 5.9 | 5.2 | 10.8 | 4.1 | 4.6 | 5.1 | 5.7 | 6.4 |
| Accounts Payable, % | 0 | 0 | 45.56 | 19.21 | 91.17 | 31.19 | 31.19 | 31.19 | 31.19 | 31.19 |
| Capital Expenditure | .0 | .0 | -.3 | -.8 | .0 | -.1 | -.1 | -.2 | -.2 | -.2 |
| Capital Expenditure, % | 0 | 0 | -2.02 | -3.01 | 0 | -1 | -1 | -1 | -1 | -1 |
| Tax Rate, % | -3.38 | -3.38 | -3.38 | -3.38 | -3.38 | -3.38 | -3.38 | -3.38 | -3.38 | -3.38 |
| EBITAT | -16.4 | -3.4 | -3.7 | -32.2 | -18.8 | -11.2 | -12.5 | -13.9 | -15.5 | -17.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -17.6 | -1.6 | -6.4 | -33.4 | -15.8 | -12.1 | -9.7 | -10.8 | -12.1 | -13.5 |
| WACC, % | 62.11 | 62.89 | 62.89 | 62.89 | 62.89 | 62.74 | 62.74 | 62.74 | 62.74 | 62.74 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -16.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -14 | |||||||||
| Terminal Value | -23 | |||||||||
| Present Terminal Value | -2 | |||||||||
| Enterprise Value | -19 | |||||||||
| Net Debt | 3 | |||||||||
| Equity Value | -22 | |||||||||
| Diluted Shares Outstanding, MM | 3 | |||||||||
| Equity Value Per Share | -8.12 |
What You Will Get
- Pre-Filled Financial Model: BIMI International Medical’s actual data facilitates accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, margins, WACC, and other critical factors.
- Instant Calculations: Automatic updates provide immediate results as you make adjustments.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
- Customizable and Reusable: Designed for versatility, allowing repeated use for comprehensive forecasts.
Key Features
- Comprehensive BIMI Data: Pre-filled with BIMI International Medical’s historical performance and future projections.
- Flexible Input Options: Modify revenue growth, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive User Interface: Streamlined, organized, and suitable for both industry experts and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring BIMI International Medical, Inc. (BIMI) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly access recalculated results, including BIMI's intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Choose This Calculator for BIMI International Medical, Inc. (BIMI)?
- Designed for Healthcare Professionals: A specialized tool tailored for analysts, CFOs, and consultants in the medical field.
- Accurate Financial Data: BIMI’s historical and projected financials are preloaded for reliable analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions relevant to the healthcare industry.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Detailed step-by-step instructions help you navigate through the calculations.
Who Should Use This Product?
- Investors: Evaluate BIMI International Medical, Inc. (BIMI)’s market position before making investment decisions.
- Healthcare Executives: Optimize financial assessments and validate growth projections.
- Entrepreneurs in Healthcare: Understand the valuation methods applied to companies like BIMI.
- Financial Consultants: Provide in-depth valuation analyses for healthcare clients.
- Students and Educators: Utilize current industry data to teach and learn valuation strategies.
What the Template Contains
- Pre-Filled Data: Includes BIMI International Medical, Inc.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze BIMI's profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.